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Abstract
The aim of this study is to give information to readers about the importance of 
glutathione peroxidase. The physiopathology of most diseases is not fully elucidated 
currently; however, in many epidemiological studies, there are limited studies 
indicating the relationship between low levels of glutathione peroxidase status and 
the rise of cancer risk in many types of cancer. Anytime, situations in case of the 
distortion due to imbalance between enzymatic and nonenzymatic antioxidants 
and oxidants which lost one of paired electrons in the atomic level mean reactive 
oxygen species (ROS) withal reactive nitrogen species (RNS) in favor of oxidants 
that are related to oxidative stress. The possible mechanisms of glutathione peroxi-
dase have been reviewed using the major findings of more than 1000 papers related 
to the ROS, glutathione peroxidase, and oxidative stress. Oxidative stress plays an 
important role in the occurrence and development of most diseases in both animal 
and human studies. Moreover, antioxidants have protective effects against nearly 50 
disease pathogenesis. Oxidative stress, which occurs as an outcome of lipid per-
oxidation, concurrently may have a key importance in the phase of carcinogenesis 
occurring with a multistage course devoted to environmental toxicity and in cancer 
pathogenesis.
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1. Introduction
1.1 Reactive oxygen species
Reactive oxygen species (ROS), superoxide radicals (O2-), hydrogen peroxide 
(H2O2), hydroxyl radical (OH-), and singlet oxygen are formed in normal oxygen 
metabolism. Free radicals can initiate free radical sequence reactions that shape 
various free radicals [1]. Reactive oxygen species have been associated with many 
disease categories, including cancer. In addition, ROSs have been reported to 
increase tumor cell migration and increase the risk of metastasis and metastasis. It 
is known that the harmful effects of ROS are controlled by various cellular defense 
systems consisting of enzymatic components (catalase, glutathione peroxidase 
and superoxide dismutase, etc.). Epidemiological literature studies have found a 
relationship between low levels of antioxidants and an increased risk of cancer [2].
Although many definitions are made for free radicals, in the general defini-
tion, free radical is a chemical product that is in molecular or atomic orbit and is 
generally highly reactive and contains unpaired electrons. The electrons in atoms 
move in spaces called orbit. Each orbit has up to two electrons moving in opposite 
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directions. Free radicals can be positively charged, negatively charged, or neutral. 
In biological systems, they occur mostly by electron transfer. Although free radical 
reactions are necessary for the defense mechanism of cells such as neutrophils and 
macrophages from immune system cells, overproduction of free radicals results in 
tissue damage and cell death [3].
Electrons are orbital in atoms and are present in pairs in the spatial region. 
Bonds are formed as a result of the interaction between atoms and molecular 
structure is formed due to these bonds. Free oxygen radicals, atomic or molecular 
structures in the single electron, are the name given to uncommon parts. These 
molecules that easily exchange electrons with other molecules are also called free 
oxygen radicals (FOR) or reactive oxygen radicals (ROR) [4].
As a result of oxidation which is a natural process during the process of metabo-
lism, the formation of free radicals, which cause various damages in the organism 
and initiator of some vital chronic diseases such as cancer and heart diseases, 
increased the interest in antioxidant compounds that combat them, and studies 
on this subject mostly focused on the determination of antioxidant activities. This 
interest is directed mainly to reactive oxygen species (ROS) damage in the aging 
process and in the etiopathogenesis of many diseases. Aging and chronic diseases in 
humans occur as a result of some complex biological processes. To understand these 
complex processes, various hypotheses have been proposed and tested experi-
mentally. The theories about aging have been explained in recent years by some 
advances in molecular genetics and experimental techniques. Increasing damage 
caused by ROS in the cell mainly involves telomere erosion, genome instability, 
DNA mutations, and changes in gene profiles in senescent cells [5, 6].
The formation of free radicals occurs during the use of oxygen in the organism. 
Unmapped electron-containing atoms or molecules initiate a sequence of reactions 
in which cells are damaged. The formation of free radicals in the body begins and 
increases with catabolic reactions as well as factors such as fatty diets, unhealthy 
nutrition, smoking, drug treatments, alcohol consumption, radiation, pesticides, 
and environmental pollution. Free radicals weaken the immune system, leading to 
various diseases and premature aging. In this respect, antioxidants are important 
in cell-protective treatment and protection from degenerative diseases. Research 
has shown that antioxidants neutralize free radicals and prevent damage to cells. In 
the context of antioxidant compounds, microalgae species have an important place 
besides terrestrial foods. When some microalgae species are grown under various 
stress conditions (nitrogen deficiency, high light intensity, high salinity, etc.), it 
is possible to accumulate in the cell pigment substances with strong antioxidant 
properties such as beta-carotene, astaxanthin, zeaxanthin, and lutein. Thus, in the 
context of biotechnology, microalgalas can be manipulated with various parameters 
in culture conditions to create various physiological stresses on cells. Thus, it can be 
ensured that the cultured cells produce more of the desired product [6].
The form of lipid peroxidation with the result of molecular oxygen conversion 
to reactive oxygen species (ROS) with various environmental factors, particularly 
cigarette smoke, alcohol, UV rays, and other oxidants, leads to oxidative stress. As a 
result of this, a multistage carcinogenesis process is favored by ROS in the body.
1.2 Oxidative stress
Oxidative stress is an important component in binding environmental toxicity to 
a multistage carcinogenic process. In addition, oxidative stress is characterized by 
the cumulative effect of more than one activity, such as a multistage process (three 
stages in a single cell; onset, elevation, and progression), such as cancer develop-
ment. Reactive oxygen species (ROS) are produced in response to endogenous and 
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exogenous stimulation. ROS can affect all these stages of carcinogenesis [7]. For this 
reason, the term oxidative stress is used to describe the imbalance between cellular 
levels of oxidants and antioxidants [8].
Cell damage caused by free radicals is believed to play an important role in the 
progression of aging process and aging-related degenerative diseases (especially 
atherosclerosis, cataract, diabetes, neurodegenerative diseases, immunosystem 
disorders, and cancer formation). Oxidative stress has been associated with almost 
50 disease pathogenesis [9].
Catalase (CAT), peroxidase (POD), glutathione reductase (GR), and superoxide 
dismutase (SOD) are enzymes that have antioxidant effects in biological and bio-
chemical systems. The antioxidant defense system protects the cell against oxidative 
damage of free radicals or other reactive molecules. Therefore, antioxidant enzymes 
such as CAT, POD, GSSG-Rx, and SOD are of great importance in this defense 
system. The harmful effects of free radicals are controlled by antioxidant defense 
systems in cells [10].
1.3 Glutathione peroxidase
Antioxidants are substances that prevent, reduce, or delay the oxidation of 
materials that may be exposed to oxidation such as proteins, lipids, carbohydrates, 
and DNA in living cells, and this is called antioxidant defense. Antioxidants are 
substances that prevent or delay the damage of free oxygen radicals on target tis-
sues. Antioxidants are classified into two categories, enzymatic and nonenzymatic. 
Enzymatic antioxidants are superoxide dismutase (SOD), catalase, and glutathione 
peroxidase (GPx), and nonenzymatic antioxidants are vitamin E, vitamin C, 
vitamin A, selenium (Se), transferrin, and lactoferrin. Antioxidants are often 
intracellular and sometimes extracellular [4]. Reduction in circulating antioxidant 
may be due to sequestration by tumor cells as well as sweeping lipid peroxides by 
tumor cells [2].
The negative aspect of ROS production is that ROS constitutes various types 
of cancer that can be resistant to exogenous growth in itself [11, 12]. For example, 
HL-60, multidrug-resistant, is resistant to growth of ROS due to the endogenous 
height of antioxidants which are detoxifying and which are ROS scavenger such 
as leukemia and CAT [11, 12]. Several oncogene-induced cancer cells enhance the 
antioxidant activity by activating nuclear factor erythroid 2-related factor 2 (NRF2) 
and maintaining the effect [12–16]. ROS levels allow the activation of pro-tumor-
igenic signaling pathways without induced cell death [12, 17]. Also, in the event 
of an increase in GSH levels, which play an active role in protecting cells from cell 
death, also appears to play an active role in protection from ROS-inducing therapy 
[12, 17]. The antioxidant defense system is a large network of molecules which 
eliminate free radicals and production of ROS [18, 19]. Endogenous antioxidant 
defense systems are available to compensate the ROS welded damage [7, 20]. These 
systems function their form by maintaining intracellular ROS activity and redox 
balance with chelating [7, 20].
Glutathione peroxidase catalyzed by the reaction catalyzed by the reduced form 
of glutathione (GSH) by reacting with hydrogen peroxide or lipid peroxides while 
playing a role in the detoxification of these molecules by creating a glutathione 
bridge with another glutathione molecule (GSSG) form [21]. H2O2 is detoxified by 
catalase and glutathione peroxidase [22].
The glutathione redox cycle plays a key role in the reduction of intracellular 
hydroperoxides. GPx belongs to the class of selenocysteine compound because 
it binds four atoms of selenium and provides the catalytic activity of glutathione 
peroxidase. It needs glutathione as a co-substrate [23].
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Glutathione is a tripeptide which is composed of cysteine, glutamic acid, and 
glycine. GSH has two structural characteristic: γ-glutamyl linkage and sulfhydryl 
(-SH) group. GSH is known for its multiple physiological functions as an anti-
oxidant against ROS and free radicals in detoxification of xenobiotic compounds 
[24–28]. When the cell fails to protect GSH content no longer, certain cell death may 
be followed [28, 29]. GSH, which is the most important antioxidant molecule of 
intracellular environment, has many physiological functions such as detoxification 
of xenobiotics, transport of amino acids, keeping sulfhydryl groups in proteins in 
the reduced state, and acting as a coenzyme in some enzymatic reactions other than 
involving antioxidant defense system [21, 30–32]. Glutathione, in reduced form 
(GSH), turns itself into oxidized glutathione (GSSG) form with creating disulfide 
bridge with another glutathione molecule while playing role in detoxification of 
these molecules by reacting with hydrogen peroxides or lipid peroxides, with the 
reaction catalyzed by the GPx enzyme. In order for the maintenance of free radical 
detoxification in cell, GSSG needs to be converted back to the reduced form. GSSG 
is converted to reduced glutathione form with GR enzyme by a reaction in which 
NADPH is used [21, 30, 33].
Glutathione peroxidase (GSH-Px; E.C. 1.11.1.9) is a cytosolic enzyme responsible 
for the reduction of hydroperoxides. In erythrocytes, GSH-Px is the most effective 
antioxidant against oxidant stress and has some important functions in phagocytic 
cells [34]:
   H 2  O 2 + 2GSH  
G P x    ⎯ → 2  H 2 O + GSSG (1)
  ROOH + 2GSH  G P x    ⎯ → ROH + GSSG +  H 2 O (2)
GPx is an enzyme responsible for the removal of hydroperoxides formed in 
cells. Since its subunits contain a Se atom, it is thought to be a selenoenzyme that 
protects cells against various damages. The presence of this enzyme was first found 
by Mills in 1957 in mammalian erythrocytes. It is the most effective enzyme in 
endothelial cells and especially in the lung. About 60–75% of enzyme activity is 
found in the eukaryotic cell cytoplasm and 25–40% is found in mitochondria. The 
most common enzyme activity is clear in erythrocytes and liver. GPx is the most 
important enzyme that protects lipids from peroxidation at intracellular distance. 
For this reason, this enzyme, especially in the cytosolic compartment of the cell, 
maintains the structure and function of the cell. The phospholipid hydroperoxide 
glutathione peroxidase (PLGSH-Px), which reduces membrane phospholipid 
hydroperoxides to alcohol, also contains the Se atom and is monomeric. It is also 
a cytosolic enzyme. PLGSH-Px provides protection against peroxidation of the 
membrane in cases where vitamin E, a membrane-bound antioxidant, is insuf-
ficient [35–37].
Glutathione peroxidase catalyzes detoxification of H2O2 and lipid peroxides 
by reduced glutathione. Thus, it protects membrane lipids and hemoglobin from 
oxidation of peroxides. GSH-Px is also involved in the detoxification of xenobi-
otics. It is the antioxidant enzyme system that provides the most vital defense 
against the peroxidative damage of biological membranes in mammalian cells. 
From these enzymes, glutathione peroxidase, catalase, and superoxide dismutase 
together form a common system aimed at protecting the cell from peroxidant 
molecules [38].
In a study, when the serum GPx (p < 0.001) levels were compared, the coro-
nary artery ectasia (CAE) patient group was significantly lower compared to 
the control group [39]. In a literature study, there was no significant difference 
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(p > 0.05) between GPx activities in both groups of patients with malignant 
tumors in the head and neck region [40]. An increase in the level of free oxygen 
radicals may cause mutagenicity, cytotoxicity, and changes in gene expression, 
leading to the development of malignant tumors, and this mutagenicity may 
contribute to the transformation of benign development into malignant [41]. In 
conclusion, high GPx activity in the blood can be considered as a factor reducing 
cancer risk. Comparison of oxidative parameters in Parkinson’s disease groups 
and control groups showed that GSH-Px was significantly higher in the patient 
group [42]. Decreased levels of GPx activities were observed in progressive 
hypothyroidism in the postnatal period [43]. Reduced activities of GPx, one of 
the most important antioxidant defense systems in the body, either reported 
increased or decreased intracellularly in different tissues antioxidant enzymes 
[44, 45]. Increased GPx activity experimental colitis was reported in the parotid 
glands of mice; decreased enzyme activity was found in submandibular glands 
[46]. The results of GPx activities in plasma in both Crohn’s disease (CD) groups 
as well as controls did not reveal any statistically significant differences [47]. 
Results of GPx and SOD activities measured in CD patients have been dem-
onstrated to be diverse when analyzing plasma samples [48]. Previous studies 
focusing on the role of GPX1 single nucleotide polymorphisms (SNPs) included 
GPX1 SNP rs1050450, which often caused the C to T mutation [49]. GPX1 SNP 
was found to affect the risk of lung cancer and bladder cancer of r1010450 [50]. 
The risk of vascular calcification and atherosclerosis is also affected by the Leu 
allele of GPX1 SNPs [51, 52]. However, available evidence did not acknowledge 
that GPX1 SNP rs1050450 plays an important role in chronic kidney disease 
(CKD) progression or renal allograft dysfunction [53, 54]. Significant influences 
of GPX1 Pro197Leu SNPs on the risk of ESRD in Han Chinese population have 
not been detected [55]. It is suggested that individuals with low GPx activity are 
prone to intact antioxidant protection leading to oxidative damage to membrane 
fatty acid and functional proteins and consequently to neurotoxic damage [56]. 
Forgione and colleagues previously hypothesized that GPX1 deficiency caused 
an increase in vascular oxidative stress with endothelial dysfunction directly 
involved [57]. Inhibition of ferroptosis by GPx4 provides protective mechanisms 
against neurodegeneration. In addition, we suggest that selenium deficiency 
increases susceptibility to ferroptotic processes and other programmed cell 
death pathways due to a decrease in GPx activity [58]. GPX1 affects the effects 
of the major factors involved in both macro and micronutrient metabolism by 
regulating gene expression, protein function, and enzyme activities [59–61]. 
Some studies [62, 63] underline the importance of maintaining an appropri-
ate expression and activity of this selenoperoxidase to control redox balance 
and glucose and lipid metabolism. GPX1 polymorphism with risk of diabetes 
and obesity in different populations [64–68]. Oxidative stress-induced intes-
tinal injury has been reduced by the addition of SOD, glutathione peroxidase, 
and N-acetylcysteine, which reduces intestinal tissue tumor necrosis factor-a 
concentrations with anti-inflammatory and antioxidant properties [69, 70]. A 
significant increase in GPx activity in the inflamed mucosa was found in either 
active or remission stage in ulcerative colitis (UC) patients. Other studies con-
firmed significantly higher plasma GPx levels in the UC and CD groups than in 
the control group [71]. Children with inflammatory bowel diseases (IBDs) had 
increased GPx activity and GSH content compared with control children [72]. 
Selenium supplementation in patients with autoimmune thyroiditis is associ-
ated with decreased antithyroperoxidase antibody levels, improved thyroid 
ultrasound characteristics, and improved quality of life [73]. ROS has been 
incorporated into cellular signaling, which may activate mitogenic cellular 
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pathways and proinflammatory processes leading to disruption of renal fibrosis 
and GPx, which support progressive impairment of renal function [74]. Total 
glutathione, decreased/oxidized glutathione, and ubiquinone were significantly 
decreased in patients with susceptibility-related diseases, while DNA fragmenta-
tion was significantly increased in patients. However, these differences were 
not associated with the GPx1 genetic background [75]. It has been reported a 
linear relationship between estrogen and GPx in erythrocytes of postmeno-
pausal women [76]. Serviddio et al. [77] showed a positive correlation between 
the activity of GPx and luteinizing hormone (LH) concentrations in healthy 
women. They also observed a significant positive correlation between estradiol 
and GPx. Significant increase in GPx activity was found in abdominal obesity 
in postmenopausal women [78]. Glutathione peroxidase (GPx) has important 
functions in the reduction of peroxides that are reported to inactivate vasodilat-
ing NO and the decomposition of S-nitrosoglutathione (GSNO), which plays 
an important role in vascular homeostasis [79]. Seleno-glutathione peroxidase 
mimic ebselen (PZ51)-protected endothelial and vascular system of spontaneous 
hypertensive rats (SHRsp) prone to stroke during pregnancy chronic hyperten-
sion [80]. It showed a significant relationship between low GPx level and vitiligo. 
Asian vitiligo patients showed lower levels of GPx than the controls, Caucasian 
populations, and healthy controls [81]. GPx polymorphism may contribute to the 
reduced GPx activity and the prevalence of vitiligo in Gujarat population [82]. In 
experimental models, GPx1 deficiency led to endothelial dysfunction, impaired 
angiogenesis, and increased infarction size and vascular permeability following 
ischemia/reperfusion injury [57, 83]. Furthermore, recent data [84] and others 
[85] showed that GPx1 deficiency provides atherosclerosis sensitivity in diabetic 
and hyperlipidemic environments, respectively. A recent study by Lubos et al. 
[86] showed that the reduction of GPx-1 activity in silenced human endothelial 
cells for GPx1 expression accelerated oxidative stress and increased nuclear factor 
kappa-light-chain-enhancer of activated B cells (NFκB) and c-Jun-N-terminal 
kinase (JNK) activation. GPx activity is associated with an increased risk of 
major adverse cardiovascular events at 1 year following an acute coronary syn-
drome. Serum GSHPx and arylesterase activity levels increased significantly after 
laryngectomy [87]. In a study [88], a decrease in GSH-Px activity was observed in 
patients with colon cancer. In another study [89], there was no difference in GPX 
or CAT activities in hypoxic and non-hypoxic patients. In one OSAS study [90], 
patients had lower GPX levels than healthy controls.
It is known that ROS have detrimental effects, which are controlled by various 
cellular defense system, consisting of enzymatic (catalase, glutathione peroxidase 
and superoxide dismutase, etc.) compounds [2, 91]. H2O2 is detoxified by catalase 
and glutathione peroxidase [22, 92]. Selenium is a trace element which is located in 
selenoenzymes, comprising thioredoxin reductase (TrxR) that is an enzyme which 
is related to the reduction of proteins and disulfides and glutathione peroxidase 
(GPx) for the detoxification of H2O2 [93–95].
Many studies show that the effect of organic and inorganic Se supplements 
on physiological functions and human health has been researched, but the most 
appropriate usage form of Se addition to dietary has not been specified [95–97].
2. Conclusion
The form of lipid peroxidation with the result of molecular oxygen conver-
sion to ROS with various environmental factors particularly smoking cigarette, 
alcohol, UV rays, and other oxidants leads to oxidative stress. As a result of this, a 
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multistage carcinogenesis process starts, and cells with diseases may occur by the 
degradation of the balance between both lipophilic and enzymatic antioxidants 
that form the antioxidant capacity of skin and ROS. Glutathione peroxidase 
activity is a primary antioxidant defense system that plays a key and fundamental 
role in the overall defense mechanisms and strategies in biological systems. There 
are at least eight GPx enzymes in humans, GPx1–GPx8. The GPx 1–8 genes are 
mapped to chromosomes 3, 14, 5, 19, 6, 6, 1, and 5, respectively. Glutathione 
peroxidases have also been implicated in the development and prevention of many 
common and complex diseases, including cancer and cardiovascular disease. 
Optimization of the nutritional status of selenium may result in higher GPx4 
activity and thus delay or even prevent neuronal loss. Increasing selenium levels 
may reduce the risk of developing neurodegenerative disease in populations with 
low selenium exposure. The brain is vulnerable to increased ROS due to its high 
metabolic rate and relatively low antioxidant defense ability. Se deficiency has 
been associated with increased oxidative stress and neurodegenerative diseases. 
The role of Se proteins in the neurodegeneration of oxidative stress and ferropose 
can provide a unique insight into the mechanisms of cellular death in neurodegen-
eration. Optimization of nutritional status of Se may result in higher GPx activity. 
In a population with low selenium uptake, the toxic effects of mercury may be 
more pronounced because the metal forms an insoluble complex with selenium, 
thereby reducing bioavailability in various antioxidant systems (e.g., glutathione 
peroxidase). Recent developments in the new field of selenium biology and GPX1 
have been shown to attempt to suggest the signaling and molecular mechanisms 
involved in glucose and lipid metabolism-related diseases. It mimics the require-
ments and opportunities of mimicking applications of various antioxidant 
enzymes in the treatment of insulin-dependent diseases. GPX enzyme is the 
main regulator of insulin physiology and energy metabolism. Hyperbaric oxygen, 
medical ozone, and enteral glutamine, alone or in combination with arginine, 
have shown positive effects on necrotizing enterocolitis (NEC) by modulating 
antioxidant defense mechanisms. Maintaining the physiological concentration of 
selenium is a prerequisite for preventing thyroid disease and maintaining general 
health. Supplementation with organic form is more effective and appears to be 
beneficial in immunological mechanisms in patients with autoimmune thyroiditis. 
Selenium supplementation has proven clinically beneficial in patients with mild 
to moderate Graves’ orbitopathy. Decreased GPx activity causes hepatocellular 
degeneration and premature death of mice. Since many harmful conditions are 
known to directly disrupt the GPx, inhibition of ferroptosis may represent a 
suitable therapeutic approach to improve hepatocyte cell death. GPx is particu-
larly vulnerable to the oxidative stress associated with hypertension. Low GPx 
levels may contribute to the pathogenesis of vitiligo in the Asian population as 
opposed to the White population. GPx1 plays a major role in vascular homeostasis. 
Specifically upregulating the activity of this isoform or designing functionally 
active mimetics may provide cardiovascular protection. GPx1 deficiency causes 
endothelial cell dysfunction and activation supporting atherogenesis. It can be 
concluded that serum GPx activity is low in patients compared to healthy control 
groups, and the balance between antioxidant and prooxidants is deteriorated in 
favor of prooxidants, and the deficiency of antioxidant enzymes in diseases may 
be a symptom in the explanation of cancer pathophysiology. The result could not 
be fully confirmed as there are some limitations. Limited numbers, small sample 
sizes, and methodological diversity may weaken statistical power. Higher quality 
studies with larger samples should be performed to confirm the results. Further 
studies are needed on this subject. We believe that this study will shed light on 
future studies.
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